Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014

Cancer Immunol Immunother. 2015 Jul;64(7):923-30. doi: 10.1007/s00262-014-1643-7. Epub 2014 Dec 30.
No abstract available

Publication types

  • Congress
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • CTLA-4 Antigen / immunology
  • Cancer Vaccines / therapeutic use
  • Germany
  • Humans
  • Immunotherapy / methods*
  • Ipilimumab
  • Neoplasms / immunology*
  • Neoplasms / therapy*
  • T-Lymphocytes, Cytotoxic / immunology
  • Tumor Microenvironment / immunology

Substances

  • Antibodies, Monoclonal
  • CTLA-4 Antigen
  • Cancer Vaccines
  • Ipilimumab